Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease
Movement Disorders Clinical Practice · 2025
DOI: 10.1002/mdc3.70143 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Maria Teresa Pellecchia und 41 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana," Neuroscience Section, University of Salerno, Salerno, Italy. Hauptthemen laut MEDLINE: Antiparkinson Agents, Dyskinesia, Drug-Induced, Dyskinesias, Levodopa. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agenzia Italiana del Farmaco, Ministero della Salute.
Abstract (Originalsprache)
Background
Evidence suggests that female gender represents a risk factor for the development of motor/nonmotor fluctuations and dyskinesia in Parkinson's disease (PD). So far, no prospective study has analyzed this aspect in relation to the introduction of levodopa treatment.
Objective
This prospective multicenter study aims to assess the development of motor/nonmotor fluctuations and dyskinesia based on gender over a 2‐year observation period in PD patients starting levodopa.
Methods
Two hundred and eighty‐nine PD patients requiring levodopa at baseline were enrolled at 17 Movement Disorders Centers and followed for 2 years. Gender differences in the development of fluctuations, defined as a score ≥2 in the 19‐item Wearing‐Off Questionnaire, and dyskinesia, defined by Movement Disorders Society Unified Parkinson's Disease Rating Scale Part IV (MDS‐UPDRS‐IV) score >0 on item 4.1 were assessed. Baseline predictors of such complications were evaluated by stepwise multivariate logistic regression analysis.
Results
Two hundred and sixteen patients (139 men, 77 women) completed the follow‐up (M24). By M24, 53,2% of men and 64.9% of women had fluctuations ( P = 0.048), whereas 5% of men and 14.3% of women developed dyskinesia ( P = 0.0185). Multivariate analysis showed that female gender significantly predicted wearing‐off (Odds ratio [OR] = 1.930; P = 0.0333), whereas older age was a significant protective factor (for 5‐year increase: OR = 0.712; P < 0.0001). Multivariate analysis showed that gender (OR = 3.405; P = 0.0228) and MDS‐UPDRS Part III score (for a 5‐unit increase: OR = 1.281; P = 0.0239) were significant predictors of dyskinesia at M24.
Conclusions
Female gender was the strongest predictor of fluctuations and dyskinesia after 2‐year intake of levodopa. This finding could have important implications for the development of gender‐oriented therapeutic recommendations in early PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana," Neuroscience Section, University of Salerno, Salerno, Italy.
- Department of Medical and Surgical Sciences, Institute of Neurology, Magna Græcia University, Catanzaro, Italy.
- Department of Experimental Medicine (DIMES), Section of Human Physiology, University of Genoa, Genoa, Italy.
- Neurorehabilitation Unit, Parkinson's Disease and Movement Disorders Center, Moriggia-Pelascini Hospital, Como, Italy.
- Medical Genetics and Neurogenetics Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Milano, Italy.
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
ORCID-Profile: Maria Teresa Pellecchia, Marina Picillo, Laura Avanzino, Roberto Ceravolo, Calogero Edoardo Cicero, Rosa De Micco, Alessio Di Fonzo, Giulia Lazzeri, Chiara Reale, Fabrizio Stocchi
Förderung
- Agenzia Italiana del Farmaco, Ministero della Salute
Zitieren
APA
Pellecchia, M. T., Picillo, M., Russillo, M. C., Amboni, M., Arabia, G., Avanzino, L., Canesi, M., Catania, A., Ceravolo, R., Cicero, C. E., Cilia, R., Colangelo, I., Dati, G., De Micco, R., De Rosa, A., Di Fonzo, A., Eleopra, R., Fetoni, V., Garavaglia, B., …, & Barone, P. (2025). Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70143
Vancouver
Pellecchia MT, Picillo M, Russillo MC, Amboni M, Arabia G, Avanzino L, et al. Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70143
BibTeX
@article{Pellecchia2025,
author = {Pellecchia, Maria Teresa and Picillo, Marina and Russillo, Maria Claudia and Amboni, Marianna and Arabia, Gennarina and Avanzino, Laura and Canesi, Margherita and Catania, Alessia and Ceravolo, Roberto and Cicero, Calogero Edoardo and Cilia, Roberto and Colangelo, Isabel and Dati, Giovanna and De Micco, Rosa and De Rosa, Anna and Di Fonzo, Alessio and Eleopra, Roberto and Fetoni, Vincenza and Garavaglia, Barbara and Giglio, Augusta and Giuntini, Martina and Invernizzi, Federica and Lazzeri, Giulia and Marchese, Roberta and Nicoletti, Alessandra and Pacchetti, Claudio and Panteghini, Celeste and Pilleri, Manuela and Radicati, Fabiana and Reale, Chiara and Scaglione, Cesa and Soricelli, Andrea and Stocchi, Fabrizio and Tessitore, Alessandro and Vacca, Laura and Volontè, Maria Antonietta and Volpi, Graziella and Zangaglia, Roberta and Amato, Francesco and Ricciardi, Carlo and Russo, Michela and Barone, Paolo},
title = {Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease},
journal = {Movement Disorders Clinical Practice},
year = {2025},
doi = {10.1002/mdc3.70143}
}
EUVIMED